Overview
Maxime Barat practices in Paris, France. Mr. Barat is highly rated in 10 conditions, according to our data. His top areas of expertise are Pelvic Congestion Syndrome, Adrenocortical Carcinoma, Pancreatic Cancer, Liver Embolization, and Vertebroplasty.
His clinical research consists of co-authoring 124 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adrenal CancerMr. Barat isAdvanced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaMr. Barat isAdvanced. Learn about Adrenocortical Carcinoma.
- Cushing's syndromeMr. Barat isAdvanced. Learn about Cushing's syndrome.
- Diverticular DiseaseMr. Barat isAdvanced. Learn about Diverticular Disease.
- Gastrointestinal Stromal TumorMr. Barat isAdvanced. Learn about Gastrointestinal Stromal Tumor.
- Neuroendocrine TumorMr. Barat isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- AdenomyosisMr. Barat isExperienced. Learn about Adenomyosis.
- Adrenal Gland AdenomaMr. Barat isExperienced. Learn about Adrenal Gland Adenoma.
- AppendicitisMr. Barat isExperienced. Learn about Appendicitis.
- Arteriovenous MalformationMr. Barat isExperienced. Learn about Arteriovenous Malformation.
- Bone TumorMr. Barat isExperienced. Learn about Bone Tumor.
- CholangitisMr. Barat isExperienced. Learn about Cholangitis.